"Neoplastic Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS.
|Neoplastic Stem Cells
- Neoplastic Stem Cells
- Cell, Neoplastic Stem
- Cells, Neoplastic Stem
- Neoplastic Stem Cell
- Stem Cell, Neoplastic
- Tumor Stem Cells
- Cell, Tumor Stem
- Cells, Tumor Stem
- Stem Cell, Tumor
- Stem Cells, Tumor
- Tumor Stem Cell
- Tumor Initiating Cells
- Cell, Tumor Initiating
- Cells, Tumor Initiating
- Initiating Cell, Tumor
- Initiating Cells, Tumor
- Tumor Initiating Cell
- Stem Cells, Neoplastic
Cancer Stem Cells
- Cancer Stem Cells
- Cancer Stem Cell
- Cell, Cancer Stem
- Cells, Cancer Stem
- Stem Cell, Cancer
- Stem Cells, Cancer
Neoplastic Colony-Forming Units
- Neoplastic Colony-Forming Units
- Colony-Forming Unit, Neoplastic
- Neoplastic Colony Forming Units
- Neoplastic Colony-Forming Unit
- Unit, Neoplastic Colony-Forming
- Units, Neoplastic Colony-Forming
- Colony-Forming Units, Neoplastic
- Colony Forming Units, Neoplastic
Below are MeSH descriptors whose meaning is more general than "Neoplastic Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Neoplastic Stem Cells".
This graph shows the total number of publications written about "Neoplastic Stem Cells" by people in this website by year, and whether "Neoplastic Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Neoplastic Stem Cells" by people in Profiles.
Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance. Ther Deliv. 2022 04; 13(4):249-273.
The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells. Cell Death Dis. 2021 10 23; 12(11):988.
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. Cancer Res. 2021 10 01; 81(19):5089-5101.
Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells. Pharm Res. 2021 Jun; 38(6):1067-1079.
bcr3 PML-RARA: short fusion, small blasts! Blood. 2021 05 13; 137(19):2708.
All-trans retinoic acid and protein kinase C a/?1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression. Sci Rep. 2021 03 15; 11(1):6044.
Survival of salivary gland cancer stem cells requires mTOR signaling. Cell Death Dis. 2021 01 21; 12(1):108.
Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy. Mol Cancer Ther. 2020 10; 19(10):2175-2185.
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck. Neoplasia. 2020 08; 22(8):283-293.
In Silico Models Accurately Predict In Vivo Response for IL6 Blockade in Head and Neck Cancer. Cancer Res. 2020 04 01; 80(7):1451-1460.